Search

Your search keyword '"Goudevenos I."' showing total 71 results

Search Constraints

Start Over You searched for: Author "Goudevenos I." Remove constraint Author: "Goudevenos I."
71 results on '"Goudevenos I."'

Search Results

1. Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice:: GLORIA-AF Registry

2. Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome—Results from the countrywide TARGET study

3. Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV—a survey from the European Society of Cardiology

4. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry

8. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: The PRESERVE EF study

10. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

12. The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

13. Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors

15. Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfate

17. Antiplatelet Efficacy of Long-Term Treatment With Clopidogrel Besylate in Patients With a History of Acute Coronary Syndrome: Comparison With Clopidogrel Hydrogen Sulfate

18. Clinical utility of Doppler echocardiography in assessing aortic stenosis severity and predicting need for intervention in children

19. Analysis of the composition of plasma lipoproteins in patients with extensive coronary heart disease using 1H NMR spectroscopy

20. Prevalence of vascular disease in metabolic syndrome using three proposed definitions

21. Management of the elderly patient with hyperlipidaemia: recent concerns

22. Markers of hepatitis viruses and human T-lymphotropic virus types I/II in patients who have undergone open-heart surgery: evidence of increased risk for exposure to HBV and HEV

23. Rare association of diffused coronary ectasia and anomalous origin of left circumflex coronary artery in a man with heterozygous familial hypercholesterolemia: a case report

28. Noninvasive indexes of left atrial diastolic function in hypertrophic cardiomyopathy

30. Isolated corrected transposition of great arteries and double left anterior descending artery originating from the left and right coronary artery. A rate combination of coronary artery anomaly and congenital heart disease

34. The effects of anxiety and depression on the needs of patients hospitalized with coronary disease.

36. Awareness, treatment and control of the metabolic syndrome and its components: A multicentre Greek study

37. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)

38. Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation. the GLORIA-AF registry

40. The burden of atrial fibrillation and heart failure in hospitalized patients: A real-world survey in a nationwide snapshot.

42. Myocardial perfusion SPECT as a potential mediator on circulating chromogranin A in patients with old myocardial infarction.

43. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study.

44. Thrombolysis through a Swan-Ganz catheter in two patients with high-risk pulmonary embolism and absolute contraindication for systemic thrombolysis.

45. The contribution of left heart disease in COPD patients with pulmonary hypertension.

46. Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery - a 867 Patient Study.

47. Impact of income status on prognosis of acute coronary syndrome patients during Greek financial crisis.

48. Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

49. Post myocardial infarction risk stratification for sudden cardiac death in patients with preserved ejection fraction: PRESERVE-EF study design.

50. Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II).

Catalog

Books, media, physical & digital resources